Delivery Order SPE2DB22D2211-SPE2DB24FMST7

Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,051.39 firm fixed-price delivery order is for the supply of MICROGESTIN FE 1.5-30 tablets. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,852.90, is for the supply of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. The contract has a period of performance through October 5, 2023 and is structured as a firm fixed-price delivery order. The contract is not designated as a set-aside....
This federal contract award, with identifier SPE2DB22D3501|SPE2DB23FXH95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,879.10 firm-fixed-price delivery order is for the supply of MICROGESTIN FE 1.5-30 TAB 28S, a pharmaceutical product, with a completion date of September 25, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $4,592.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MICROGESTIN FE 1.5-30 TAB 28S, a pharmaceutical product, with a completion date of February 22, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with ID SPE2DB20D3505|SPE2DB22FU3C3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,043.81 delivery order is for the supply of MICROGESTIN FE 1.5-30 TAB 28S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The award, worth $6,685.83, is for the supply of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. The award has a completion date of April 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
This federal contract award, with ID SPE2DX15D3005|SPE2DX24F3MTS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, with a ceiling value of $4,245.19 and a completion date of November 7, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MICROGESTIN FE 1-20 TABLET 28S. The contract has a ceiling value of $1,159.34 and an ultimate completion date of December 1, 2023. This is a Firm Fixed Price Delivery Order contract, and there was no set-aside used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency (DLA) is for the delivery of pharmaceutical products, including Microgestin FE 1-20 tablets, with a ceiling value of $1,929.72. The contract is a firm fixed-price Delivery Order with a completion date of December 22, 2021. This award is not designated with a set-aside requirement, indicating full and open competition. Amerisourcebergen maintains a significant Indefinite...
This federal contract award is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,514.81 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 27, 2023, with a completion date of September 28, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FMST7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,009.19 Firm Fixed Price Delivery Order contract covers the provision of MICROGESTIN FE 1.5-30 TAB 28S, a type of prescription medication, with a period of performance through February 2, 2024.

Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated with a set-aside requirement, indicating open competition.

Generated 5/14/25, 10:27 AM